Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects/Experiment 1/Signature 2
From BugSigDB
< Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects | Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects/Experiment 1
Source: Figure 2G-H
Description: Impact of LTBI on the intestinal microbiota of patients with UC. LEfSe analysis highlights the enriched microbial taxa in non-LTBI (Enterobacteriaceae) and LTBI (Streptococcaceae, Sutterellaceae, Burkholderiales) groups. LDA analysis shows the impact of specific taxa on group differences (Enterobacteriaceae in non-LTBI; Sutterellaceae in LTBI).
Abundance in Group 1: decreased abundance in ulcerative colitis patients with latent tuberculosis infection (AB0)
Revision editor(s): Nuerteye
